Taribavirin hydrochloride

Description: Taribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor designed to concentrate within the liver to target HCV-infected hepatocytes, while minimizing distribution within red blood cells and the development of hemolytic anemia [2]. Target: Others. Smiles: Cl.NC(=N)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O. References: Abd-Rabou AA, et al. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer. Pharm Res. 2018 Feb 27,35(4):76.